pcDNA3 myc CIITA (P#808) Citations (7)

Originally described in: Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
Kanazawa S, Okamoto T, Peterlin BM Immunity. 2000 Jan . 12(1):61-70. PubMed Journal

---

Articles Citing pcDNA3 myc CIITA (P#808)

Articles
Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits. Schlahsa L, Zhang H, Battermann A, Verboom M, Immenschuh S, Eiz-Vesper B, Stripecke R, Engelmann K, Blasczyk R, Figueiredo C. Transfusion. 2014 Aug;54(8):1961-70. doi: 10.1111/trf.12631. Epub 2014 Mar 28. PubMed
Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display. Tveita A, Fauskanger M, Bogen B, Haabeth OA. Oncotarget. 2016 Oct 11;7(41):67175-67182. doi: 10.18632/oncotarget.11946. PubMed
Swine Leukocyte Antigen Class II Is a Xenoantigen. Ladowski JM, Reyes LM, Martens GR, Butler JR, Wang ZY, Eckhoff DE, Tector M, Tector AJ. Transplantation. 2018 Feb;102(2):249-254. doi: 10.1097/TP.0000000000001924. PubMed
HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. Jin YP, Valenzuela NM, Zhang X, Rozengurt E, Reed EF. J Immunol. 2018 Apr 1;200(7):2372-2390. doi: 10.4049/jimmunol.1701259. Epub 2018 Feb 23. PubMed
Causal ALS genes impact the MHC class II antigen presentation pathway. Chi B, Ozturk MM, Paraggio CL, Leonard CE, Sanita ME, Dastpak M, O'Connell JD, Coady JA, Zhang J, Gygi SP, Lopez-Gonzalez R, Yin S, Reed R. Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2305756120. doi: 10.1073/pnas.2305756120. Epub 2023 Sep 18. PubMed
SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2. Taefehshokr N, Lac A, Vrieze AM, Dickson BH, Guo PN, Jung C, Blythe EN, Fink C, Aktar A, Dikeakos JD, Dekaban GA, Heit B. J Cell Sci. 2024 May 15;137(10):jcs262172. doi: 10.1242/jcs.262172. Epub 2024 May 22. PubMed
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers. Cheong TC, Jang A, Wang Q, Leonardi GC, Ricciuti B, Alessi JV, Di Federico A, Awad MM, Lehtinen MK, Harris MH, Chiarle R. Nat Commun. 2024 Jun 14;15(1):5110. doi: 10.1038/s41467-024-49499-0. PubMed

If you have published an article using this material, please email us at to have your article added to this page.